Michael N. Dretsch

Michael N. Dretsch

Auto-generated profile, based on publicly available information

Michael N. Dretsch

U.S. Army Medical Research Directorate-West, Walter Reed Army Institute of Research, Joint Base Lewis-McChord, WA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2017 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
DRD. Rangaprakash
D. Rangaprakash
GDGopikrishna Deshpande
Gopikrishna Deshpande
TDThomas A. Daniel
Thomas A. Daniel
AGAdam M. Goodman
Adam M. Goodman
JRJennifer L. Robinson
Jennifer L. Robinson
MDMichael N. Dretsch
Michael N. Dretsch
Objectives: Military service members risk acquiring posttraumatic stress disorder (PTSD) and mild‐traumatic brain injury (mTBI), with high comorbidity. Owing to overlapping symptomatology in chronic mTBI or postconcussion syndrome (PCS) and PTSD, it is difficult to assess the etiology of a patient's condition without objective measures. Using resting‐state functional MRI in a novel framework, we tested the hypothesis that their neural signatures are characterized by functionally hyperconnected brain regions which are less variable over time. Additionally, we predicted that such connectivities possessed the highest ability in predicting the diagnostic membership of a novel subject (top‐predictors) in addition to being statistically significant.Methods: U.S. Army Soldiers (N = 87) with PTSD and comorbid PCS + PTSD were recruited along with combat controls. Static and dynamic functional connectivities were evaluated. Group differences were obtained in accordance with our hypothesis. Machine learning classification (MLC) was employed to determine top predictors.Results: From whole‐brain connectivity, we identified the hippocampus‐striatum connectivity to be significantly altered in accordance with our hypothesis. Diffusion tractography revealed compromised white‐matter integrity between aforementioned regions only in the PCS + PTSD group, suggesting a structural etiology for the PCS + PTSD group rather than being an extreme subset of PTSD. Employing MLC, connectivities provided worst‐case accuracy of 84% (9% more than psychological measures). Additionally, the hippocampus‐striatum connectivities were found to be top predictors and thus a potential biomarker of PTSD/mTBI.Conclusions: PTSD/mTBI are associated with hippocampal‐striatal hyperconnectivity from which it is difficult to disengage, leading to a habit‐like response toward episodic traumatic memories, which fits well with behavioral manifestations of combat‐related PTSD/mTBI. Hum Brain Mapp 38:2843–2864, 2017. © 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.

17 December 2015 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
MDMichael N. Dretsch
Michael N. Dretsch
KWKathy Williams
Kathy Williams
TETanja Emmerich
Tanja Emmerich
GCGogce Crynen
Gogce Crynen
GAGhania Ait‐Ghezala
Ghania Ait‐Ghezala
GIGrant L Iverson
Grant L Iverson
Background: In addition to experiencing traumatic events while deployed in a combat environment, there are other factors that contribute to the development of posttraumatic stress disorder (PTSD) in military service members. This study explored the contribution of genetics, childhood environment, prior trauma, psychological, cognitive, and deployment factors to the development of traumatic stress following deployment.Methods: Both pre‐ and postdeployment data on 231 of 458 soldiers were analyzed. Postdeployment assessments occurred within 30 days from returning stateside and included a battery of psychological health, medical history, and demographic questionnaires; neurocognitive tests; and blood serum for the D2 dopamine receptor (DRD2), apolipoprotein E (APOE), and brain‐derived neurotropic factor (BDNF) genes.Results: Soldiers who screened positive for traumatic stress at postdeployment had significantly higher scores in depression (d = 1.91), anxiety (d = 1.61), poor sleep quality (d = 0.92), postconcussion symptoms (d = 2.21), alcohol use (d = 0.63), traumatic life events (d = 0.42), and combat exposure (d = 0.91). BDNF Val66 Met genotype was significantly associated with risk for sustaining a mild traumatic brain injury (mTBI) and screening positive for traumatic stress. Predeployment traumatic stress, greater combat exposure and sustaining an mTBI while deployed, and the BDNF Met/Met genotype accounted for 22% of the variance of postdeployment PTSD scores (R2 = 0.22, P < 0.001). However, predeployment traumatic stress, alone, accounted for 17% of the postdeployment PTSD scores.Conclusion: These findings suggest predeployment traumatic stress, genetic, and environmental factors have unique contributions to the development of combat‐related traumatic stress in military service members.

15 July 2016 in Journal of Neurotrauma
Verified
Journal Article
Closed access
TETanja Emmerich
Tanja Emmerich
LALaila Abdullah
Laila Abdullah
GCGogce Crynen
Gogce Crynen
MDMichael Dretsch
Michael Dretsch
JEJames Evans
James Evans
FCFiona C Crawford
Fiona C Crawford
In the military population, there is high comorbidity between mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) due to the inherent risk of psychological trauma associated with combat. These disorders present with long-term neurological dysfunction and remain difficult to diagnose owing to their comorbidity and overlapping clinical presentation. Therefore, we performed cross-sectional analysis of blood samples from demographically matched soldiers (total n = 120) with mTBI, PTSD and mTBI + PTSD and those who were considered cognitively and psychologically normal. Soldiers were genotyped for apolipoprotein E (APOE) ε4 and phospholipids (PL) were examined using liquid chromatography/mass spectrometry (LC/MS) analysis. We observed significantly lower levels of several major PL classes in TBI, PTSD and TBI+PTSD compared to controls. PTSD severity analysis revealed that significant PL decreases were primarily restricted to the moderate-to-severe PTSD group. An examination of degree of unsaturation showed that monounsaturated fatty acid (MUFA) containing phosphatidylcholine (PC) and phosphatidylinositol (PI) species were lower in the TBI and TBI+PTSD groups. However these PLs were unaltered among PTSD subjects compared to controls. Similarly, ether PC (ePC) levels were lower in PTSD and TBI+PTSD subjects relative to controls. Ratios of arachidonic acid (AA) to docosahexaenoic acid (DHA) containing species were significantly decreased within PC and PE classes. APOE ε4 (+) subjects exhibited higher PL levels than their APOE ε4 (-) counterparts within same diagnostic groups. These findings suggest that PL profiles, together with APOE genotyping, could potentially aid to differentiate diagnosis of mTBI and PTSD and warrant further validation. In conclusion, PL profiling may facilitate clinical diagnosis of mTBI and PTSD, currently hindered by comorbid pathology and overlapping symptomology of these two conditions.

1 January 2016 in Journal of Head Trauma Rehabilitation
Verified
Journal Article
Closed access
MDMichael Dretsch
Michael Dretsch
JBJoseph Bleiberg
Joseph Bleiberg
KWKathy Williams
Kathy Williams
JCJesus Caban
Jesus Caban
JKJames Kelly
James Kelly
TDThomas DeGraba
Thomas DeGraba
Objective: To examine the use of the Neurobehavioral Symptom Inventory to measure clinical changes over time in a population of US service members undergoing treatment of mild traumatic brain injury and comorbid psychological health conditions. Setting: A 4-week, 8-hour per day, intensive, outpatient, interdisciplinary, comprehensive treatment program at the National Intrepid Center of Excellence in Bethesda, Maryland. Participants: Three hundred fourteen active-duty service members being treated for combat-related comorbid mild traumatic brain injury and psychological health conditions. Design: Repeated-measures, retrospective analysis of a single-group using a pretest-posttest treatment design. Main Measures: Three Neurobehavioral Symptom Inventory scoring methods: (1) a total summated score, (2) the 3-factor method, and (3) the 4-factor method (with and without orphan items). Results: All 3 scoring methods yielded statistically significant within-subject changes between admission and discharge. The evaluation of effect sizes indicated that the 3 different Neurobehavioral Symptom Inventory scoring methods were comparable. Conclusion: Findings indicate that the different scoring methods all have potential for assessing clinical changes in symptoms for groups of patients undergoing treatment, with no clear advantage with any one method.

Verified
Journal Article
Open access
PDF file
SHSteven D. Hicks
Steven D. Hicks
RORobert P. Olympia
Robert P. Olympia
COCayce Onks
Cayce Onks
RKRaymond Y. Kim
Raymond Y. Kim
KZKevin J. Zhen
Kevin J. Zhen
FMFrank A. Middleton
Frank A. Middleton
Recurrent concussions increase risk for persistent post-concussion symptoms, and may lead to chronic neurocognitive deficits. Little is known about the molecular pathways that contribute to persistent concussion symptoms. We hypothesized that salivary measurement of microribonucleic acids (miRNAs), a class of epitranscriptional molecules implicated in concussion pathophysiology, would provide insights about the molecular cascade resulting from recurrent concussions. This hypothesis was tested in a case-control study involving 13 former professional football athletes with a history of recurrent concussion, and 18 age/sex-matched peers. Molecules of interest were further validated in a cross-sectional study of 310 younger individuals with a history of no concussion (n = 230), a single concussion (n = 56), or recurrent concussions (n = 24). There was no difference in neurocognitive performance between the former professional athletes and their peers, or among younger individuals with varying concussion exposures. However, younger individuals without prior concussion outperformed peers with prior concussion on three balance assessments. Twenty salivary miRNAs differed (adj. p < 0.05) between former professional athletes and their peers. Two of these (miR-28-3p and miR-339-3p) demonstrated relationships (p < 0.05) with the number of prior concussions reported by younger individuals. miR-28-3p and miR-339-5p may play a role in the pathophysiologic mechanism involved in cumulative concussion effects.

15 February 2017 in Journal of Neurotrauma
Verified
Journal Article
Closed access
MDMichael N. Dretsch
Michael N. Dretsch
NSNoah Silverberg
Noah Silverberg
AGAndrew J. Gardner
Andrew J. Gardner
WPWilliam J. Panenka
William J. Panenka
TETanja Emmerich
Tanja Emmerich
GIGrant L Iverson
Grant L Iverson
Risk factors for concussion in active-duty military service members are poorly understood. The present study examined the association between self-reported concussion history and genetics (apolipoprotein E [APOE], brain-derived neurotrophic factor [BDNF], and D2 dopamine receptor genes [DRD2]), trait personality measures (impulsive-sensation seeking and trait aggression-hostility), and current alcohol use. The sample included 458 soldiers who were preparing to deploy for Operation Iraqi Freedom/Operation Enduring Freedom. For those with the BDNF Met/Met genotype, 57.9% (11/19) had a history of one or more prior concussions, compared with 35.6% (154/432) of those with other BDNF genotypes ( p = 0.049, odds ratio [OR] = 2.48). APOE and DRD2 genotypes were not associated with risk for past concussions. Those with the BDNF Met/Met genotype also reported greater aggression and hostility personality characteristics. When combined in a predictive model, prior military deployments, being male, and having the BDNF Met/Met genotype were independently associated with increased lifetime history of concussions in active-duty soldiers. Replication in larger independent samples is necessary to have more confidence in both the positive and negative genetic associations reported in this study.